If Democrats retake the House, the gavel of the Health Subcommittee of the Ways and Means Committee could go to Representative Lloyd Doggett of Texas, an unyielding critic of what he calls price gouging by pharmaceutical companies.
“Drug companies have been in such a strong position, and they have contributed so generously to people in both parties, they’ve been pretty well able to block anything,” Mr. Doggett said. “But I do believe that there is now a public outcry, a real pent-up demand, that we take action.”
